ArticleFrontiers in nutrition2025
α-Glucosidase inhibitory activity of polyphenol-rich sugarcane extract: screening and mechanistic insights based on biolayer interferometry-mass spectrometry.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- In Vitro Antioxidant Activity and Dual-Target Inhibitory Effects of Dipyridamole on α-Amylase and α-Glucosidase: Molecular Mechanisms and Molecular Dynamics Simulations.Biomolecules · 2026Article
- Integrating GBS-Derived SNP Markers with Phytochemical Profiling and Anti-Obesity Enzyme Inhibition inMolecules (Basel, Switzerland) · 2026Article
- Phenolic Composition Profile and Antidiabetic Activities of Jack Bean [Preventive nutrition and food science · 2026Article
- Ultrasound-Assisted Extraction of Polyphenols fromMolecules (Basel, Switzerland) · 2026Article
- Impact of Acute (Poly)Phenol-Rich Sugarcane Extract Consumption on Postprandial Glycemic Response in Healthy Adults: A Randomized Crossover Study.Foods (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polyphenol-rich sugarcane extract (PRSE) contains bioactive compounds with potential hypoglycemic properties, but its direct interaction with α-glucosidase has not been explored. Methods: This study investigated the inhibitory mechanism of PRSE on α-glucosidase using enzyme kinetics. Bioactive compounds with α-glucosidase-binding affinity were identified through biolayer interferometry-mass spectrometry (BLI-MS), and the binding mechanisms were further explored via molecular docking analysis. Results and discussion: PRSE was found to inhibit α-glucosidase through a mixed-type mechanism. A total of 29 compounds, including 4 coumarins, 9 phenolic acids, and 16 flavonoids, were identified in the PRSE dissociation solution. Representative compounds included coumarin, kaempferol, apigenin 7-o-neohesperidoside, and vicenin 3. Notably, apigenin 7-o-neohesperidoside and vicenin 3 were identified for the first time as potential α-glucosidase inhibitors.These compounds interacted with key residues of α-glucosidase, such as Asp and Glu, via hydrogen bonding, π-anion interactions, and hydrophobic forces. These findings suggest that PRSE could serve as a promising natural source of α-glucosidase inhibitors. The application of BLI-MS proved effective for screening target bioactive compounds in plant extracts. PRSE may have potential applications in functional foods for postprandial glycemic control and type 2 diabetes prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.